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In "The Impact of Concomitant Empiric Cefepime on Patient Outcomes of Methicillin-Resistant *Staphylococcus aureus* Bloodstream Infections Treated with Vancomycin", Open Forum Infectious Diseases, Volume 6, Issue 7, July 2019, ofz077, eCollection 2019 July, in [Table 3](#T3){ref-type="table"}, the adjusted odds ratio (95% CI) for vancomycin + cefepime should have read 1.023 (0.435--2.425) and the adjusted odds ratio (95% CI) for endocarditis should have read 2.767 (1.216--6.073). The correct version of the table is displayed below. The noted changes do not alter the findings or conclusions. The authors regrets this mistake.

###### 

Multivariable Logistic Regression for Factors Independently Associated With 30-Day Mortality

  Variable                         OR (95% CI)            Adjusted OR (95% CI)
  -------------------------------- ---------------------- ----------------------
  Vancomycin + cefepime            3.073 (1.495--6.317)   1.023 (0.435--2.425)
  Lower respiratory tract source   4.412 (2.419--8.046)   3.808 (1.799--8.057)
  APACHE II                        1.109 (1.074--1.146)   1.081 (1.043--1.121)
  Age                              1.054 (1.032--1.077)   1.041 (1.016--1.066)
  Endocarditis                     1.635 (0.858--3.116)   2.767 (1.216--6.073)
  ID consult                       0.467 (0.238--0.914)   0.502 (0.222--1.133)
  Charlson comorbidity index       1.146 (1.026--1.280)   
  Source control                   0.332 (0.165--0.667)   

Hosmer-Lemeshow goodness-of-fit test *P* = .252; variance inflation factor 1--5 for all variables included at model entry.

Abbreviations: APACHE II, Acute Physiology and Chronic Health Evaluation II; CI, confidence interval; ID, Infectious Diseases; OR, odds ratio.
